The fight against childhood cancer is one of our many missions. Treatments are key when it comes to combating the many forms of cancer that affect children. The FDA is making real progress! Recently we approved a treatment for patients as young as 12+ with previously untreated Stage III/IV Hodgkin lymphoma. #ChildhoodCancerMonth